Learn about BYETTA, the BYETTA Pen. Important Safety Information for BYETTA (exenatide) injection. Contraindications. BYETTA is contraindicated in. Exenatide (Byetta) is the first in a new class of incretin peptide mimetics .. Available at ; accessed October 15, 3. Meneilly. Exenatide (marketed as Byetta, Bydureon) is a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist) medication, belonging to the group of incretin.
|Published (Last):||3 April 2017|
|PDF File Size:||1.43 Mb|
|ePub File Size:||2.60 Mb|
|Price:||Free* [*Free Regsitration Required]|
Each pen contains 60 doses. Byetta did not significantly alter the pharmacodynamic properties e. Corticorelin Corticotropin releasing hormone Sauvagine Urocortin Antagonists: National Center for P InformationU.
A small air bubble in the cartridge is normal. Byetta has not been studied in patients with severe gastrointestinal disease, including gastroparesis.
This page was last edited on 14 Novemberat Support Center Support Center. For more information about Byettta, go to www. If not, turn dose knob away from you clockwise until it stops and the is in the dose window.
In patients taking warfarin, prothrombin time should be monitored more frequently after initiation or alteration of Byetta therapy.
Exenatide – Wikipedia
Some events occurred in patients who had been experiencing nausea, vomiting, or diarrhea, with or without dehydration. Keep a list of them with you to show your healthcare provider and pharmacist each time you get a new medicine. The patient should be advised not to share the pen and needles. The dose may be administered subcutaneously in the thigh, abdomen, or upper arm.
Welcome to BYETTA.com!
When Byetta is used in combination with insulin, the dose of byegta should be evaluated. In Combination with Metformin and a Sulfonylurea 30 Weeks. Patients were between the ages of 19 and 78 years, with a mean age of If you cannot turn the dose knob, see Commonly Asked Questions, number 7, in Section 4 of user manual.
Safety and effectiveness of Byetta have not been established in pediatric patients.
Food and Drug Administration. Orexin AB Antagonists: The primary endpoints of the study were glycemic control measured by HbA 1C and safety. Because exenatide is cleared primarily by the kidney, hepatic dysfunction is not expected to affect blood concentrations of exenatide [see Clinical Pharmacology Retrieved February 25, See How Supplied section for a complete list of available packages of Byetta.
All studies were conducted over a week period and were placebo controlled. See “What is the most important information I should know about Byetta? Pen-sharing poses a risk for transmission of blood-borne pathogens.
Add BYETTA to insulin glargine as a complementary action to help improve glycemic control
Therefore, OC products should be administered at least one hour prior to Byetta injection. When Byetta is used in combination with insulin, evaluate the dose of insulin.
The pain may happen with or without vomiting. Acetaminophen AUC, C max and T max were not significantly changed when acetaminophen was given 1 hour before Byetta injection.
Patients should be informed of the potential risks bbyetta benefits of Byetta and of alternative modes of therapy. Caution should be exercised when Byetta is administered to a nursing woman. The most common side effects with BYETTA include nausea, vomiting, diarrhea, feeling jittery, dizziness, headache, acid stomach, constipation, and weakness.
The mean apparent volume of distribution of exenatide following SC administration of a single dose of Byetta is